It is the process of keeping fertilized eggs in controlled laboratory conditions for several days so that embryos may develop to the blastocyst stage, usually around day 5 or 6.

A blastocyst is a developed embryo with a fluid-filled cavity, an inner cell mass and an outer trophectoderm cell layer. These cell groups contribute to different tissues during development.

Many embryos reach the blastocyst stage around day 5 or day 6 after fertilization. Developmental timing varies, and some laboratories may assess embryos beyond day 6 in selected cases.

A day-3 embryo is generally at the cleavage stage, consisting of a small number of cells. A blastocyst has developed further, forming a cavity and distinguishable inner cell mass and trophectoderm.

No. Some fertilized eggs stop developing before the blastocyst stage. The proportion that reaches blastocyst varies with patient factors, embryo characteristics and laboratory conditions.

It can improve embryo selection and may be associated with higher success per transfer in some patient groups. However, results vary, and extended culture can also lead to no embryo being available for transfer. It does not guarantee pregnancy.

No. Suitability depends on factors such as the number of embryos, age, previous IVF history, clinical goals and laboratory capability. Your fertility specialist can explain the options for your cycle.

There may be no embryo available for blastocyst transfer or freezing in that cycle. The team may review embryo development and discuss the findings and possible options for future treatment.

Some day-6 blastocysts are suitable for transfer or freezing. Their significance depends on morphology, any genetic testing results, laboratory policy and the clinical context; day of development alone does not determine the outcome.

Not necessarily. Day of development is one factor among several. Embryo morphology, genetic information when available, patient factors and clinic-specific evidence all contribute to clinical decisions.

Grading describes morphological features such as expansion and the appearance of the inner cell mass and trophectoderm. It helps embryologists assess embryos but is not a guarantee of implantation or live birth.

No. A good morphological grade may be useful for selection, but implantation and live birth also depend on factors that grading cannot fully measure, including embryo genetics and the uterine environment.

Some embryos with less favorable morphological grades can result in pregnancy and live birth. The meaning of a grade should be discussed with the embryology team rather than interpreted as a certainty.

No. Culture and morphological grading do not establish chromosomal status. Preimplantation genetic testing is a separate procedure that may be considered for specific indications.

No. Blastocyst culture refers to growing embryos to a developmental stage. PGT-A is a genetic testing procedure that may involve biopsy of cells from a blastocyst; it is not automatically performed during culture.

Yes. Suitable blastocysts can commonly be cryopreserved using vitrification and stored for possible future treatment, subject to the clinic’s assessment and applicable consent and storage requirements.

It is a transfer in which a previously frozen blastocyst is warmed and placed into the uterus in a later cycle after the lining has been prepared according to the treatment plan.

There is no single answer for every patient. The choice depends on clinical factors such as hormone levels, uterine lining, OHSS risk, genetic testing plans and the overall treatment strategy.

Transferring more than one embryo increases the risk of a multiple pregnancy. Even a single embryo transfer can rarely result in identical twinning. The number of embryos transferred should be discussed with the clinician.

Single embryo transfer can reduce the risk of twins or higher-order multiple pregnancy while aiming for a singleton pregnancy. Whether it is appropriate depends on the individual clinical circumstances.

Blastocyst culture is performed in the laboratory and is not a procedure carried out inside the patient’s body. Egg retrieval and embryo transfer are separate procedures, each with their own preparation and possible discomfort.

Embryos are maintained in carefully controlled laboratory conditions, but not all embryos continue to develop. Extended culture provides additional developmental information and also carries the possibility that no embryo will be suitable for transfer.

Yes, when genetic testing is indicated and performed, suitable embryos may be considered for transfer based on the test result, embryo assessment and the clinic’s protocols. Testing has limitations and should be explained by the clinical team.

It may. Some embryos that could have been frozen at an earlier stage may not reach blastocyst in culture. The number ultimately frozen depends on embryo development and laboratory criteria.

Factors can include egg and sperm characteristics, patient age, embryo genetics, stimulation and fertilization circumstances, culture media, incubator conditions and laboratory handling. No single factor determines the outcome in every case.

Yes. Some embryos arrest before reaching the blastocyst stage. Embryo arrest is a recognized possibility during IVF and can occur for multiple biological and laboratory-related reasons.

Yes. Embryos created through ICSI may be cultured to the blastocyst stage, just as embryos created through conventional insemination may be. The fertilization method and culture duration are distinct parts of treatment.

Ask your fertility specialist or embryologist to explain how many eggs were retrieved, how many fertilized, how embryos developed, and what the laboratory observed. They can discuss what the result means for your individual treatment options.

Not necessarily. Implantation is a biological process that takes place after transfer and varies between embryos. A transfer itself does not confirm implantation; the clinic will advise when pregnancy testing should be performed.

Ask why it is recommended for you, how many embryos are developing, what the risk of having no embryo to transfer may be, how day-5 and day-6 embryos are handled, and what alternatives are available. Discuss the expected benefits and limitations in your own clinical context.